Financial information

Financial guidance 2020

MorphoSys published its financial guidance 2020 on March 18, 2020.

in € million

Guidance 2020
(PUBLISHED MARCH 18, 2020)

Results 2019

Group Revenues 280 to 290 71.8
R&D expenses 130 to 140 108.4
Group EBIT -15 to 5 - 107.9

This guidance does not include revenues generated from tafasitamab and revenues from future collaborations and/or licensing agreements. Revenues are expected to include royalty income from Tremfya® of €37 to €42 million. The guidance is based on constant currency exchange rates and does not include any contributions from tafasitamab revenues and any effects from potential in-licensing or co-development deals for new development candidates. The operational and financial guidance does not include a potential impact of the ongoing global COVID-19 crisis on MorphoSys’ business operations including but not limited to the Company’s supply chain, clinical trial conduct, as well as timelines for regulatory and commercial execution. 

Fundamentals of
MorphoSys Group

Business Segments

MorphoSys is one of the world’s leading biotechnology companies focusing on fully human antibodies. With its proprietary technologies, MorphoSys is developing the next generation of therapeutic antibodies. MorphoSys is committed to create significant value for its employees, shareholders, customers and partners through a sustainable business strategy balancing short-term and long-term growth potentials. 

PARTNERED DISCOVERY

MorphoSys's Partnered Discovery segment applies the Company's proprietary technologies targeting to the research, development and optimization of therapeutic antibody drug candidates in partnerschips with pharmaceutical and biotechnology companies. While the development costs are borne by the respective partner, MorphoSys profits further from successful programs via milestone payments and potential royalties on product sales.

PROPRIETARY DEVELOPMENT

In the second segment, Proprietary Development, MorphoSys develops innovative proprietary antibody products to generate added value for the Company. MorphoSys's scientists concentrate on indications such as inflammatory and autoimmune diseases, as well as cancer and infectious diseases. In this segment, the compounds are developed independently (or in a co-development setting) to proof clinical efficacy before being out-licensed to pharmaceutical or biotechnology companies for late-stage development and marketing.

More information about our proprietary product portfolio can be found here.

Related Links

Financial Reports

 
PDF-Download
Online Version
Order Printed Version

2020

  1. Half-Year Report 2020

    Download
    Online
    Order
     
  2. 1st Quarter Interim Statement 2020

    Download
    Online
    Order
     

2019

  1. Form 20-F 2019

    Download
    Online
    Order
     
  2. Financial Statements 2019 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. 3rd Quarter Interim Statement 2019

    Download
    Online
    Order
     
  4. Half-Year Report 2019

    Download
    Online
    Order
     
  5. 1st Quarter Interim Statement 2019

    Download
    Online
    Order
     

2018

  1. Form 20-F incl. Management Report

    Download
    Online
    Order
     
  2. Financial Statements 2018 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. 3rd Quarter Interim Statement 2018

    Download
    Online
    Order
     
  4. Half-Year Report 2018

    Download
    Online
    Order
     
  5. 1st Quarter Interim Statement 2018

    Download
    Online
    Order
     

2017

  1. Financial Statements 2017 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. 3rd Quarter Interim Statement 2017

    Download
    Online
    Order
     
  3. Half-Year Report 2017

    Download
    Online
    Order
     
  4. 1st Quarter Interim Statement 2017

    Download
    Online
    Order
     

2016

  1. Annual Report 2016

    Download
    Online
    Order
  2. Financial Statements 2016 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. 3rd Quarter Interim Statement 2016

    Download
    Online
    Order
     
  4. Half-Year Report 2016

    Download
    Online
    Order
     
  1. 1st Quarter Interim Statement 2016

    Download
    Online
    Order
     

2015

  1. Financial Statements 2015 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2015

    Download
    Online
    Order
     
  3. Nine Months' Report 2015

    Download
    Online
    Order
     
  4. Six Months' Report 2015

    Download
    Online
    Order
     
  5. Three Months’ Report 2015

    Download
    Online
    Order
     

2014

  1. Financial Statements 2014 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2014

    Download
    Online
    Order
     
  3. Nine Months' Report 2014

    Download
    Online
    Order
     
  4. Six Months' Report 2014

    Download
    Online
    Order
     
  5. Three Months' Report 2014

    Download
    Online
    Order
     

2013

  1. Financial Statements 2013 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2013

    Download
    Online
    Order
     
  3. Nine Months' Report 2013

    Download
    Online
    Order
     
  4. Six Months' Report 2013

    Download
    Online
    Order
     
  5. Three Months' Report 2013

    Download
    Online
    Order
     

2012

  1. Consolidated Financial Statements (IFRS) 2012

    Download
    Online
    Order
     
  2. Financial Statements 2012 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2012

    Download
    Online
    Order
     
  4. Six Months' Report 2012

    Download
    Online
    Order
     
  5. Three Months' Report 2012

    Download
    Online
    Order
     

2011

  1. Consolidated Financial Statements (IFRS) 2011

    Download
    Online
    Order
     
  2. Financial Statements 2011 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2011

    Download
    Online
    Order
     
  4. Six Months' Report 2011

    Download
    Online
    Order
     
  5. Three Months' Report 2011

    Download
    Online
    Order
     

2010

  1. Consolidated Financial Statements (IFRS) 2010

    Download
    Online
    Order
     
  2. Financial Statements 2010 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2010

    Download
    Online
    Order
     
  4. Six Months' Report 2010

    Download
    Online
    Order
     
  5. Three Months’ Report 2010

    Download
    Online
    Order
     

In-house produced with firesys